Close 2026-08-21 1267 scanned A

FISCHER

Fischer Medical Ventures
Small capRs 2,496 crRs 6.9 cr traded a day
Close on 2026-08-21
38.14
−2.08%
52-week range8% of the way up
31.21117.71
Market cap
2,496 cr
Net margin
-7.3%
1 month
-2.3%
Below 52w high
208.6%
RSI (14)
47
Daily swing
4.2%
average true range
Volume
0.5×
vs 20-day average
Traded
Rs 7 cr
median day
Close200-day averageMaterial filing
50100Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26
260 sessions · hover for the filing behind a move
1 week
−1.29%
1 month
−2.28%
3 months
+1.73%
6 months
−0.73%
1 year
−64.13%

The read

written from the numbers on this page
The evidence leans negative0 supporting, 4 against, 1 worth knowing

Supporting

  • nothing the data supports either way

Against

  • trading 2% below its 200-day average
  • at 8% of its 52-week range — nearly everyone who bought in the past year is underwater
  • down 64% over twelve months
  • 1 of the scans it matches has historically underperformed the market

Worth knowing

  • the 50-day and 200-day averages disagree, which usually means a turn in progress rather than a trend to lean on
What would change this read: a close back above 39, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.

How it has performed

price return over each window, measured against zero
-1.3%1W-2.3%1M+1.7%3M-0.7%6M-64.1%1Y

What the scans say today

1 of 47 matched on 2026-08-21
FISCHER matches 1 of the 47 scans today, across 1 different kinds of evidence.

Recent filings

from the exchange, newest first
M&A filings were typically +0.23pt vs the market over the next 5 sessions (n=981) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520)

The business

from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
861019816.1%19.0%-7.3%Q2 FY26Q3 FY26Q4 FY26
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.

Going for it

  • nothing clear in the filed numbers

Going against it

  • net margin narrowed from 19.0% to -7.3%
Quarter-by-quarter numbers, as filed
QuarterRevenueProfit before taxNet profitEPSNet margin
Q4 FY26
2026-03-31 · consolidated
98-2-7-7.3%
Q3 FY26
2025-12-31 · consolidated
10121190.3019.0%
Q2 FY26
2025-09-30 · consolidated
8617142.1516.1%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.

Where the price stands

the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+0.5%
Versus 200-day average-2.4%
Below 52-week high-67.6%
Above 52-week low+22.2%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)47.1
Higher closes in last 52 of 5
Six-month return−0.73%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.23%
Volume versus 20-day0.5x
Median daily turnoverRs 6.9 cr